---
$id: https://graph.org.ai/products/commodity/51294509
$type: Product
source: UNSPSC
code: "51294509"
title: "Metioxate"
class: "51294500"
classTitle: "Antidepressant piperidines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metioxate

**UNSPSC Code**: 51294509
**Class**: [Antidepressant piperidines](Antidepressant piperidines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antibiotic with the molecular formula C22H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 00V69U1QC7 chemically known as 2-(4-methylpiperidino)ethyl 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo(5,4-f)quinoline-8-carboxylate but generally known as metioxate, which bears US NIH Compound Identifier 3047729. European Medicines Agency schedules Metioxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08890MIG. The term METIOXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16. ). Most nations schedule metioxate under HS 29349990 and SITC 51579. As of Q4 2014, METIOXATE remains the US FDA Preferred Term for this commodity. Metioxate bears US NLM identifiers UMLS ID C1881807 and NCI Concept Code C66127. SMILES: CCN1C=C(C(=O)C2=C1C=CC3=C2SC(=O)N3C)C(=O)OCCN4CCC(CC4)C.

